Observational Study to Assess Glycosylated Hemoglobin Changes After 6 Months of Treatment With Pioglitazone.

NCT00449553 · clinicaltrials.gov ↗

COMPLETED

Status

326

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus

Interventions

DRUG: Pioglitazone and sulphonylurea
DRUG: Pioglitazone and sulphonylurea
DRUG: Pioglitazone and metformin
DRUG: Pioglitazone and metformin

Sponsor

Takeda

Collaborators

[object Object]